News

orange__line
100% Recruitment Achieved of PHERGain study!

The goal of this multinational, open-label, randomized phase II clinical trial is to assess the early metabolic effects of neoadjuvant treatment with trastuzumab and pertuzumab, with or without endocrine therapy...
READ MORE...
AACR Annual Meeting 2019 Highlights

Once again, MedSIR attended the 2019 annual meeting of the American Association for Cancer Research. Atlanta was the city chosen this year to host this international congress that gathers experts from all sectors...
READ MORE...
SLLIP study Poster Presentation at AACR 2019

The results of the SLLIP analysis have been scheduled for presentation in a Poster Session at the AACR Annual Meeting 2019 in Atlanta, Georgia, and were published in the 2019 Proceedings of the AACR...
READ MORE...
MedSIR at AACR 2019

The American Association of Cancer Research (AACR), founded in 1907, has the mission to cure and prevent cancer by promoting research, education, communication and patient advocacy around the globe. The AACR’s 2019 annual meeting will take...
READ MORE...
100% Recruitment Achieved of LINGain sub-study!

We are pleased to announce that LINGain sub-study “Prospective evaluation of predictive/prognostic immunogenicity biomarkers for target therapy in HER2-positive early breast cancer within the PHERGain...
READ MORE...
POST ASCO GU 2019

The MedSIR Project Development team attended the 2019 Genitourinary (GU) Cancers Symposium held in San Francisco, CA on February 14-16. It was a great opportunity to meet our scientific collaborators, business partners, and friends...
READ MORE...
MedSIR will attend The BCC 2019

We are very happy to announce that the 16th St. Gallen International Breast Cancer Conference will be held in Vienna, Austria, better known as “the city of dreams" or “city of music” from March 20-23, 2019. Vienna is...
READ MORE...
ASCO-GU
MedSIR is back to San Francisco for ASCO GU 2019

MedSIR will attend the Genitourinary Cancers Symposium (ASCO GU) for the second time in a row. The GU Symposium, now in its 15th year, will take place in San Francisco, CA from February...
READ MORE...
PREPARATORY PROJECTS FOR H2020 PROPOSALS (HORIZONTE-CV)

MEDICA SCIENTIA INNOVATION RESEARCH SL, has received financial support from IVACE through the HORIZONTE-CV Program and financial support from the European...
READ MORE...